December 2018, compared to those for the same period ended 31st of December 2019. The consolidate financial statement reported a net loss of 17.29 million baht in the year ending 21st of December 2019, as
-off the license for publication in accordance with the current situation of Baht 204.45 million. Moreover, the Group could control costs and expenses more effectively. Conclusion : The Group reported a
, in order to disclose as the information to the investor and public. Consolidated Operating Results for Quarter 2/2017, the company reported a net profit of Baht 14.82 million, compared to the same
explain our performance of the year 2017 ended December 31, 2017. The details are as follows: 1. For the year 2017, the company reported the revenue from sales of 1,562.6 million Baht, increased 6.8% from
31, 2017, the company reported total assets at THB 900.31 million, total liabilities at THB 77.17 million and shareholders' equity at THB 823.14 million. The company’s Debt-to-equity ratio was 0.094
. Conclusion : The Group reported a profit for the three-month period ended 31 March 2018, showed a loss of Baht 39.12 million. Compared to the same period of 2018, the loss was Baht 56.12 million, an increasing
Laboratory and Research Center (“AMARC”). Costs and Expenses The Company reported the consolidated costs and expenses for Q1/2019 of Baht 345.54 million, nearby of Q1/2018 of Baht 345.61 million decreased by
. would like to inform the financial results for the second quarter of 2019. The Company and its subsidiary reported a net profit of THB 131. 25 million, comparing to a net profit of THB 126. 43 million in
. Conclusion : The Group reported a profit for the six-month period ended 30 June 2018, showed a loss of Baht 86.24 million. Compared to the same period of 2018, the loss was Baht 140.04 million, decreasing of